Open Ledger
Eli Lilly financials in Beancount
Eli Lilly keeps 6 recorded periods through FY2026Q2 as a balanced Beancount ledger — inspect the figures below, then open the live books.
Updated
Latest figures
- Revenue
- $12.2B (12,200 MUSD)
- Net income
- $2.9B (2,928 MUSD)
- Net margin
- 24.0%
Recorded history
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2021 | December 31, 2021 | $28.3B (28,318 MUSD) | $5.7B (5,663 MUSD) |
FY2022 | December 31, 2022 | $28.5B (28,542 MUSD) | $6B (5,993 MUSD) |
FY2023 | December 31, 2023 | $34B (34,023 MUSD) | $5.1B (5,103 MUSD) |
FY2024 | December 31, 2024 | $45B (45,043 MUSD) | $10.4B (10,359 MUSD) |
FY2025 | December 31, 2025 | $58B (58,000 MUSD) | $14.5B (14,500 MUSD) |
Recorded revenue and net income in MUSD (Quarter periods).
| Period | Period end | Revenue | Net income |
|---|---|---|---|
FY2026Q2 | June 30, 2026 | $12.2B (12,200 MUSD) | $2.9B (2,928 MUSD) |
Coverage
Coverage6
FY2021FY2022FY2023FY2024FY2025FY2026Q2
Earnings analyses
More companies in this sector
- Hims HersHims & Hers Q2 2026 Earnings: Revenue Up 38% to $753M as GAAP Swings to an $86M Loss
- Novo NordiskNovo Nordisk H1 2026 Earnings: DKK 175.3B Sales, DKK 69.5B Net Profit, Outlook 'Raised' to 0% to −6%
- MedtronicMedtronic FY2027 Q1 Earnings: $9.76B Revenue, a 53-Week Calendar, and Cardiac Ablation at +88%